Since the introduction of NBS for MCAD deficiency, a new subgroup of newborns has been identified with variant ACADM genotypes that have not been seen before in clinically ascertained patients with classical ACADM genotypes. This evidence concerns the gene ACADM and medium chain acyl-CoA dehydrogenase deficiency.